RANDI DILLON: Open Payments
NPI 1811408404 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 48 payments from 11 companies in 2025. Trend: 2023 $2,433 · 2024 $1,850 · 2025 $907
Food & beverage: $811Education: $96
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $328 |
| UCB, Inc. | 10 | $151 |
| Janssen Biotech, Inc. | 7 | $127 |
| Amgen Inc. | 4 | $93 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Lilly USA, LLC | 3 | $52 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Galderma Laboratories, L.P. | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| Janssen Pharmaceuticals, Inc | 1 | $13 |
Products named: RINVOQ, Bimzelx, TREMFYA, SKYRIZI, Otezla, DUPIXENT, COSENTYX, TALTZ.
Industry payments across WV — which companies pay providers there.
